Go Pro
→ Universal Basic Income ALREADY exists (From Freedom Financial) (Ad)tc pixel Free CLLS Stock Alerts

Cellectis (CLLS) Financials

Cellectis logo
$2.84 +0.07 (+2.53%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$2.83 -0.01 (-0.35%)
As of 07/24/2026 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cellectis

Annual Income Statements for Cellectis

This table shows Cellectis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -23 -67 -207 -177 -230 -151 -114 -106 -101 -37 -68
Consolidated Net Income / (Loss)		 -23 -67 -104 -88 -115 -97 -125 -114 -108 -37 -68
Net Income / (Loss) Continuing Operations		 -23 -67 -104 -88 -115 -54 -97 -99 -117 -37 -68
Total Pre-Tax Income 		-23 -67 -104 -88 -115 -54 -97 -99 -116 -37 -68
Total Operating Income		 -31 -67 -93 -105 -124 -51 -103 -90 -106 -60 -33
Total Gross Profit		 -31 45 23 9.99 3.80 49 29 17 0.02 42 73
Total Revenue		 -31 45 25 13 15 51 39 19 0.76 42 73
Operating Revenue		 -31 45 25 13 15 51 30 19 0.76 42 73
Total Cost of Revenue		 0.00 0.00 2.62 2.74 11 1.95 1.84 1.77 0.74 0.00 0.00
Total Operating Expenses		 0.00 112 124 124 135 100 140 114 106 101 106
Selling, General & Admin Expense		 0.00 43 45 47 43 23 23 17 17 19 20
Research & Development Expense		 0.00 78 79 77 92 77 118 98 88 91 94
Other Operating Expenses / (Income)		 0.00 -9.76 -0.23 -0.03 0.09 0.36 -0.49 -1.38 1.30 -8.56 -7.28
Total Other Income / (Expense), net		 8.38 0.05 -2.50 25 16 -2.76 6.73 -2.38 -11 23 -35
Interest Expense		 - 7.10 18 3.81 3.63 16 6.49 18 41 22 51
Interest & Investment Income		 - 7.15 7.26 21 12 4.85 13 8.88 21 44 16
Income Tax Expense		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.09 0.37 0.00 -0.42
Net Income / (Loss) Attributable to Noncontrolling Interest		 - 0.00 104 88 115 16 11 7.89 7.38 0.00 0.00
Basic Earnings per Share		 - ($1.91) ($2.78) ($1.93) ($2.41) - ($2.55) ($2.33) - ($0.41) ($0.67)
Weighted Average Basic Shares Outstanding		 - - 35.96M 42.43M 42.47M 42.78M 44.82M 45.68M 71.75M 100.09M 100.34M
Diluted Earnings per Share		 - ($1.91) ($2.78) ($1.93) ($2.41) ($1.91) ($2.55) ($2.33) ($1.77) ($0.41) ($0.67)
Weighted Average Diluted Shares Outstanding		 - - 35.96M 42.43M 42.47M 42.78M 44.82M 45.68M 71.75M 100.09M 100.34M
Basic & Diluted Earnings per Share		 - ($1.91) - - - - - - - ($0.41) ($0.67)
Weighted Average Basic & Diluted Shares Outstanding		 - - 35.96M 42.43M 42.47M 42.78M 45.48M 45.68M 71.75M 100.09M 100.34M

Quarterly Income Statements for Cellectis

No quarterly income statements for Cellectis are available.

Annual Cash Flow Statements for Cellectis

This table details how cash moves in and out of Cellectis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 12 -85 -9.28 -71 -96 -107 -204 -89 -53 -34 -26
Net Cash From Operating Activities		 17 -33 -16 -67 -84 -104 -185 -87 -76 -49 -19
Net Cash From Continuing Operating Activities		 17 -38 -16 -67 -84 -104 -185 -69 -76 -49 -19
Net Income / (Loss) Continuing Operations		 -23 -67 -104 -88 -115 -151 -222 -114 -108 -37 -68
Consolidated Net Income / (Loss)		 -23 -67 -104 -88 -115 -151 -222 -114 -108 -37 -68
Depreciation Expense		 1.94 2.21 3.37 2.38 6.88 7.83 14 18 19 20 20
Non-Cash Adjustments To Reconcile Net Income		 33 32 103 19 21 58 35 16 13 -32 29
Changes in Operating Assets and Liabilities, net		 3.97 -5.33 -18 -0.58 3.29 -19 -13 1.22 0.37 -0.54 -0.42
Net Cash From Investing Activities		 -4.21 -53 4.78 -3.45 -12 -44 -19 -2.76 -1.07 -2.58 -2.36
Net Cash From Continuing Investing Activities		 -4.21 -53 4.78 -3.45 -12 -44 -19 -2.32 -1.07 -2.58 -2.36
Purchase of Property, Plant & Equipment		 -4.32 -14 -2.38 -4.72 -13 -44 -19 -2.44 -1.07 -2.58 -2.36
Net Cash From Financing Activities		 -0.63 0.49 0.08 0.17 0.00 24 0.00 1.15 25 18 -5.38
Net Cash From Continuing Financing Activities		 -0.63 0.62 0.08 0.17 0.00 24 0.00 -7.51 25 18 -5.38
Repayment of Debt		 -0.63 -0.09 -0.04 -0.13 - 0.00 0.00 -13 -5.11 -5.00 -5.38
Issuance of Debt		 0.00 0.00 - 0.00 0.00 24 0.00 5.75 30 23 0.00
Cash Interest Paid		 - - - - 0.00 0.03 0.37 - 0.33 0.85 0.61
Cash Interest Received		 - - 1.37 6.91 6.87 1.72 0.97 - 3.63 6.56 8.43

Quarterly Cash Flow Statements for Cellectis

No quarterly cash flow statements for Cellectis are available.

Annual Balance Sheets for Cellectis

This table presents Cellectis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/1/2016 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 371 331 333 501 467 469 382 261 334 384 325
Total Current Assets		 364 255 57 455 392 315 225 122 75 170 167
Accounts Receivable		 0.00 0.00 2.75 2.97 2.96 16 30 15 0.57 21 14
Other Current Assets		 0.00 0.00 54 - 36 30 9.67 9.08 75 5.53 153
Plant, Property, & Equipment, net		 0.00 17 7.23 7.28 24 153 193 170 55 83 39
Total Noncurrent Assets		 0.00 69 269 35 52 30 2.70 32 153 132 65
Noncurrent Note & Lease Receivables		 - - 9.52 16 - -76 -72 -49 -22 -34 -20
Other Noncurrent Operating Assets		 0.00 67 258 18 51 104 72 59 175 165 85
Total Liabilities & Shareholders' Equity		 371 398 333 501 467 469 382 261 587 385 534
Total Liabilities		 24 626 333 783 92 953 1,005 667 587 253 534
Total Current Liabilities		 24 626 653 17 63 52 49 48 544 54 456
Accounts Payable		 7.20 9.72 9.46 16 29 25 24 21 19 19 17
Other Current Liabilities		 15 576 615 1.53 13 20 17 19 525 27 439
Total Noncurrent Liabilities		 0.00 0.00 -320 765 49 901 955 619 43 657 78
Capital Lease Obligations		 - - - 0.33 47 - - - 8.50 - 7.70
Other Noncurrent Operating Liabilities		 0.00 - -320 744 2.86 29 21 21 35 545 71
Total Equity & Noncontrolling Interests		 310 -228 -0.30 -286 458 -482 -584 -351 0.00 -326 0.00
Total Preferred & Common Equity		 309 -230 -0.30 -327 355 -507 -599 -359 0.00 -326 0.00
Total Common Equity		 -201 -230 -0.30 -327 -426 -507 -599 -359 0.00 -326 0.00

Quarterly Balance Sheets for Cellectis

No quarterly balance sheets for Cellectis are available.

Annual Metrics And Ratios for Cellectis

This table displays calculated financial ratios and metrics derived from Cellectis' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 35,959,462.00 42,430,069.00 42,465,669.00 42,780,186.00 45,484,310.00 45,675,968.00 71,751,201.00 100,093,873.00 100,339,441.00
DEI Adjusted Shares Outstanding		 0.00 0.00 35,959,462.00 42,430,069.00 42,465,669.00 42,780,186.00 45,484,310.00 45,675,968.00 71,751,201.00 100,093,873.00 100,339,441.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -5.77 -4.16 -5.43 -3.53 -2.51 -2.32 -1.41 -0.37 -0.67
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -22 -47 -65 -74 -86 -36 -72 -63 -74 -42 -23
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -26.16% -870.60% 13.10% -300.65%
Earnings before Interest and Taxes (EBIT)		 -23 -67 -84 -96 -116 -42 -95 -83 -97 -60 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -21 -65 -81 -94 -109 -34 -81 -65 -79 -40 -13
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -258 471 -605 663 -896 -119 -90 -33 364 125 -229
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -22 -541 -0.29 -737 72 155 173 143 -295 -461 -256
Increase / (Decrease) in Invested Capital		 237 -518 540 -737 809 83 18 -30 -438 -167 206
Book Value per Share		 $0.00 $0.00 ($0.01) ($9.08) ($10.05) ($11.95) ($14.01) ($7.89) $0.00 ($4.55) $0.00
Tangible Book Value per Share		 $0.00 $0.00 ($0.05) ($9.12) ($10.07) ($11.98) ($14.05) ($7.91) ($0.01) ($4.57) $0.00
Total Capital		 312 -228 -0.30 -285 504 397 359 240 8.50 -318 7.70
Total Debt		 2.09 0.00 0.00 0.33 47 879 943 591 8.50 8.39 7.70
Total Long-Term Debt		 0.00 0.00 0.00 0.33 47 872 935 583 8.50 0.00 7.70
Net Debt		 2.09 -255 0.00 -451 -294 638 757 501 8.50 -135 7.70
Capital Expenditures (CapEx)		 4.21 14 -4.78 3.45 12 44 19 2.44 1.07 2.58 2.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 342 -626 -596 -14 -12 29 -1.23 -7.95 -468 -19 -289
Debt-free Net Working Capital (DFNWC)		 342 -371 -596 437 329 270 184 82 -468 124 -289
Net Working Capital (NWC)		 340 -371 -596 437 329 263 176 74 -468 116 -289
Net Nonoperating Expense (NNE)		 0.92 20 39 15 29 62 53 51 34 -4.93 44
Net Nonoperating Obligations (NNO)		 -332 -313 0.00 -451 -385 638 757 494 -295 -135 -256
Total Depreciation and Amortization (D&A)		 1.94 2.21 3.37 2.38 6.88 7.83 14 18 19 20 20
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($2.78) ($1.93) ($2.41) ($1.91) ($2.55) ($2.33) ($1.77) ($0.41) ($0.67)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 35.96M 42.43M 42.47M 42.78M 45.48M 45.68M 57.01M 100.09M 100.34M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($2.78) ($1.93) ($2.41) ($1.91) ($2.55) ($2.33) ($1.77) ($0.41) ($0.67)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 35.96M 42.43M 42.47M 42.78M 45.48M 45.68M 57.01M 100.09M 100.34M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($2.78) ($1.93) $0.00 $0.00 ($2.55) $0.00 $0.00 ($0.41) ($0.67)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 35.96M 42.43M 42.47M 42.78M 45.48M 45.68M 71.75M 100.09M 100.34M
Normalized Net Operating Profit after Tax (NOPAT)		 -22 -47 -65 -74 -86 -36 -72 -63 -74 -42 -23
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Cellectis

No quarterly metrics and ratios for Cellectis are available.


Financials Breakdown Chart

Cellectis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cellectis' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 10 years, Cellectis' net income changed from -$22.61 million in 2015 to -$67.59 million in 2025, a change of 199.0%. See Cellectis' forecast for analyst expectations on what's next for the company.

Cellectis' total operating income in 2025 was -$33.08 million, based on the following breakdown:
  • Total Gross Profit: $72.95 million
  • Total Operating Expenses: $106.03 million

Over the last 10 years, Cellectis' total revenue changed from -$30.98 million in 2015 to $72.95 million in 2025, a change of -335.4%.

Cellectis' total liabilities were at $534.32 million at the end of 2025, a 111.6% increase from 2024, and a 2,112.6% increase since 2015.

Over the last 10 years, Cellectis' book value per share changed from 0.00 in 2015 to 0.00 in 2025, a change of 0.0%.


Related Companies

Financial statements for NASDAQ:CLLS last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel